Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABCA1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ABHD12 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | ABHD13 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ABHD16B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ABHD17B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ABI3BP | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
mRNA | ABLIM2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | ABLIM3 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | ABRACL | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | ABT1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |